← back to search

Wenguang Liang

Bayer (United States) · US
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Alzheimer's disease research and treatments, Protein Structure and Dynamics, Enzyme Structure and Function, and Mitochondrial Function and Pathology.
h-index
17
citations
966
works
39
NIH funding
primary concept
email

Recent publications

Structural basis for the mechanisms of human presequence protease conformational switch and substrate recognition
Nature Communications 2022cited by 21position: firstdoi
Degradation of Alzheimer’s Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme
Journal of Molecular Biology 2021cited by 42position: middledoi
Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments
Journal of Biological Chemistry 2020cited by 17position: middledoi
Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states
Structure 2020cited by 15position: firstdoi
Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening
European Journal of Medicinal Chemistry 2019cited by 22position: middledoi
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
eLife 2018cited by 149position: middledoi
Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination
Journal of Molecular Biology 2017cited by 87position: middledoi
ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics
Nature Communications 2017cited by 35position: middledoi
Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3
Proceedings of the National Academy of Sciences 2016cited by 81position: firstdoi
In vivo epidermal migration requires focal adhesion targeting of ACF7
Nature Communications 2016cited by 57position: middledoi
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Nature Communications 2015cited by 97position: middledoi
Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease
Structure 2014cited by 63position: middledoi
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
Proceedings of the National Academy of Sciences 2013cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wei‐Jen Tang · University of Chicago12 papers (2013–2022)Jordan M Mancl · University of Chicago3 papers (2020–2022)Feng Yang · Ministry of Education of the People's Republic of China2 papers (2016–2017)Xuewen Gou · University of Chicago2 papers (2016–2017)David E. Lee · Duke University2 papers (2018–2022) · 2 papers (2018–2019)Shohei Koide · NYU Langone Health2 papers (2013–2018)Bridget Carragher · New York Structural Biology Center2 papers (2018–2022)Hui Wei · Nanchang University2 papers (2018–2022)Clinton S. Potter · Chan Zuckerberg Initiative (United States)2 papers (2018–2022)Anthony A. Kossiakoff · University of Chicago2 papers (2017–2018)Akiko Koide · NYU Langone Health2 papers (2013–2018)Xiaoyang Wu · Nantong University2 papers (2016–2017)Minglei Zhao · Sun Yat-sen University2 papers (2020–2022)Jiping Yue · University of Chicago2 papers (2016–2017)L.J. Bailey · University of Wisconsin–Madison2 papers (2017–2018) · 2 papers (2018–2019)John V. Lin King · University of California, San Francisco2 papers (2014–2022)Lauren A. McCord · University of Chicago2 papers (2013–2018)Sheng Li · Sun Yat-sen University2 papers (2018–2022)